Vystar Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Vystar Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $342.0K | Apr 23, 2019 |
| FY2018 | Dec 31, 2017 | $16.8K | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | $40.2K | Mar 29, 2018 |
| FY2016 | Dec 31, 2015 | $47.3K | Apr 14, 2017 |
| FY2015 | Dec 31, 2014 | $651.0K | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $332.7K | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $540.2K | Jun 4, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.8K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $136.0K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $525.9K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $116.5K | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | $1.67M | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | $20.98M | May 17, 2022 |
| FY2020 | Dec 31, 2019 | $13.69M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $342.0K | Jul 7, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.8K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $69.6K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $384.6K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($388.7K) | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | ($241.9K) | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | $10.97M | May 17, 2022 |
| FY2020 | Dec 31, 2019 | $6.35M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($43.8K) | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | ($4.7K) | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | $19.7K | Mar 29, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.53M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $759.5K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($5.24M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($3.96M) | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | ($2.70M) | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | ($7.61M) | May 17, 2022 |
| FY2020 | Dec 31, 2019 | ($7.70M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($5.40M) | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | ($1.18M) | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | ($1.22M) | Mar 29, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.06M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($1.52M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($1.54M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($2.95M) | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | ($3.80M) | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | ($4.84M) | May 17, 2022 |
| FY2020 | Dec 31, 2019 | ($4.94M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($3.72M) | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | ($1.13M) | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | ($1.08M) | Mar 29, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $100.0K | Apr 14, 2025 |
| FY2018 | Dec 31, 2018 | $2.40M | Apr 23, 2019 |
| FY2014 | Dec 31, 2014 | $0 | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | $22.2K | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $37.0K | Jun 4, 2014 |
| FY2012 | Dec 31, 2011 | $68.4K | Jun 20, 2013 |
| FY2011 | Dec 31, 2010 | $70.6K | Mar 30, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($180.4K) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($100.0K) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($442.7K) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($515.5K) | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | ($2.86M) | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | ($2.26M) | May 17, 2022 |
| FY2020 | Dec 31, 2019 | ($1.51M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($1.51M) | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | ($499.0K) | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | ($907.4K) | Mar 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $115.4K | May 17, 2022 |
| FY2021 | Dec 31, 2020 | $130.2K | May 17, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $452.5K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $553.3K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $712.4K | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $11.64M | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | $16.86M | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | $22.66M | May 17, 2022 |
| FY2020 | Dec 31, 2019 | $22.40M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $2.47M | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | $307.4K | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | $234.5K | Mar 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.84M | Apr 14, 2025 |
| FY2024 | Dec 31, 2023 | $9.75M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | $12.36M | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | $22.76M | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | $29.42M | May 17, 2022 |
| FY2020 | Dec 31, 2019 | $23.63M | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $4.34M | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | $3.16M | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | $3.06M | Mar 29, 2018 |
| FY2016 | Dec 31, 2015 | $3.04M | Apr 14, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.51M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($5.26M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($7.25M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($2.01M) | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | ($7.56M) | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | ($7.36M) | May 17, 2022 |
| FY2020 | Dec 31, 2019 | ($2.56M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($1.87M) | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | ($2.86M) | Apr 23, 2019 |
| FY2018 | Dec 31, 2016 | ($2.82M) | Apr 23, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $147.1K | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | $460.3K | May 17, 2022 |
| FY2020 | Dec 31, 2019 | $460.3K | Apr 16, 2021 |
| FY2020 | Jul 18, 2019 | $313.2K | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | $147.1K | Jul 7, 2020 |
| FY2014 | Dec 31, 2014 | $106.0K | Apr 15, 2015 |
| FY2012 | Dec 31, 2012 | $68.0K | Jun 20, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($61.38M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($59.85M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($60.61M) | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | ($55.37M) | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | ($51.41M) | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | ($48.71M) | May 17, 2022 |
| FY2020 | Dec 31, 2019 | ($41.10M) | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | ($33.40M) | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | ($28.00M) | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | ($26.81M) | Mar 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $73.8K | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | $56.4K | Apr 15, 2015 |
| FY2014 | Dec 31, 2012 | $91.9K | Apr 15, 2015 |
| FY2013 | Dec 31, 2011 | $16.7K | Jun 4, 2014 |
| FY2012 | Dec 31, 2010 | $282.6K | Jun 20, 2013 |
| FY2011 | Dec 31, 2009 | $780.1K | Mar 30, 2012 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $4.28M | May 17, 2022 |
| FY2020 | Dec 31, 2020 | $2.04M | Apr 16, 2021 |
| FY2020 | Dec 31, 2019 | $1.71M | Apr 16, 2021 |
| FY2017 | Dec 31, 2017 | $881.7K | Mar 29, 2018 |
| FY2014 | Dec 31, 2014 | $0 | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | $83.7K | Apr 15, 2015 |
| FY2013 | Dec 31, 2012 | $184.7K | Jun 4, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 0 | May 17, 2022 |
| FY2021 | Dec 31, 2020 | 0 | May 17, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24.62M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 17.40M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 12.94M | Apr 14, 2025 |
| FY2023 | Dec 31, 2022 | 12.94M | Sep 6, 2024 |
| FY2022 | Dec 31, 2021 | 12.94M | Oct 10, 2023 |
| FY2021 | Dec 31, 2020 | 1.12B | May 17, 2022 |
| FY2020 | Dec 31, 2019 | 1.11B | Apr 16, 2021 |
| FY2019 | Dec 31, 2018 | 457.75M | Jul 7, 2020 |
| FY2018 | Dec 31, 2017 | 132.81M | Apr 23, 2019 |
| FY2017 | Dec 31, 2016 | 114.95M | Mar 29, 2018 |